Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Adularia Logo
Adularia Growth Score
21
CB Rank
237662
Heat Score
37
Adularia is a microbial-based therapy for Colorectal cancer.
Founded
obfuscation
PrivateGrant Zürich, Zurich, Switzerland1-10 www.adularia.ch/
Biotechnology
Overview

Adularia
Total Funding
obfuscation
Growth Score
21
Heat Score
37

Total Funding
obfuscation
Grant raised
obfuscation
Growth Score21
-5 pts
in past quarter
Heat Score 37
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Adularia

CB Rank
237662
Adularia is a microbial-based therapy for Colorectal cancer.
Founded
obfuscation
PrivateGrant Zürich, Zurich, Switzerland1-10 www.adularia.ch/
Biotechnology

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Details

Legal Name Recolony AG
Also Known As Recolony
Operating Status Active
Company Type For Profit
About the Company
Adularia is a microbial-based therapy for Colorectal cancer.
Contact Email info@recolony.ch
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Microbial-based Immunotherapy for Colorectal Cancer
A synthetic small molecule therapy that activates tumor-associated macrophages to stimulate an anti-tumor immune response in colorectal cancer patients.
AI-Powered Drug Compound Discovery Platform
A platform using generative AI and physics-informed machine learning to design and optimize small molecule drug candidates for immunotherapy.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Adularia Logo
Grant - Adularia
1
obfuscation
USZ Health Innovation HubGrant
obfuscation
Grant - Adularia Logo
Grant - Adularia
1
obfuscation
USZ Health Innovation HubGrant
obfuscation
Grant - Adularia Logo
Grant - Adularia
1
obfuscation
USZ Health Innovation HubGrant
obfuscation
Grant - Adularia Logo
Grant - Adularia
1
obfuscation
USZ Health Innovation HubGrant
obfuscation
Grant - Adularia Logo
Grant - Adularia
1
obfuscation
USZ Health Innovation HubGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Adularia Logo
Grant - Adularia
1
obfuscation
USZ Health Innovation HubGrant
obfuscation
Grant - Adularia Logo
Grant - Adularia
1
obfuscation
USZ Health Innovation HubGrant
obfuscation
Grant - Adularia Logo
Grant - Adularia
1
obfuscation
USZ Health Innovation HubGrant
obfuscation
Grant - Adularia Logo
Grant - Adularia
1
obfuscation
USZ Health Innovation HubGrant
obfuscation
Grant - Adularia Logo
Grant - Adularia
1
obfuscation
USZ Health Innovation HubGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
USZ Health Innovation Hub Logo
USZ Health Innovation Hub
Yes
Grant - Adularia Logo
Grant - Adularia
—
USZ Health Innovation Hub Logo
USZ Health Innovation Hub
Yes
Grant - Adularia Logo
Grant - Adularia
—
USZ Health Innovation Hub Logo
USZ Health Innovation Hub
Yes
Grant - Adularia Logo
Grant - Adularia
—
USZ Health Innovation Hub Logo
USZ Health Innovation Hub
Yes
Grant - Adularia Logo
Grant - Adularia
—
USZ Health Innovation Hub Logo
USZ Health Innovation Hub
Yes
Grant - Adularia Logo
Grant - Adularia
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Feb 20, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 5, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

60
-84.96%
 in past month

Active Website Tech Count

4Adularia is actively using 4 technologies for its website, according to BuiltWith. These include Common Crawl, Organization Schema, and  CommonCrawl Top 50m.

Total IP

2Adularia has registered 2 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Adularia's headquarters? Adularia is located in Zürich, Zurich, Switzerland.Who invested in Adularia? Adularia has 2 investors including USZ Health Innovation Hub and  Venture Kick.When was the last funding round for Adularia? Adularia closed its last funding round on
obfuscation
from a Grant round.Who are Adularia's competitors? Alternatives and possible competitors to Adularia may include MaaT Pharma, Seres Therapeutics, and  Vedanta Biosciences.How much funding has Adularia raised to date? Adularia has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d42803 1)
|